|
Originally published In Press as doi:10.1074/jbc.M107165200 on October 11, 2001
J. Biol. Chem., Vol. 276, Issue 50, 47087-47093, December 14, 2001
Short Term Effect of Aldosterone on Na,K-ATPase Cell Surface
Expression in Kidney Collecting Duct Cells*
Vanessa
Summa §,
David
Mordasini§¶,
Frank
Roger¶,
Marcelle
Bens ,
Pierre-Yves
Martin¶,
Alain
Vandewalle ,
François
Verrey **, and
Eric
Féraille¶
From the Institute of Physiology, University of
Zürich, Zürich, CH-8057 Switzerland, the ¶ Division of
Nephrology and Department of Pathology, University of Geneva, CH-1211
Geneva, Switzerland, and INSERM, Unité 478, Faculté
de Médecine Xavier-Bichat,
75870 Paris Cedex 18, France
Received for publication, July 27, 2001, and in revised form, October 4, 2001
 |
ABSTRACT |
Aldosterone controls extracellular volume and
blood pressure by regulating Na+ reabsorption, in
particular by epithelia of the distal nephron. A main regulatory site
of this transcellular transport is the epithelial sodium channel (ENaC)
that mediates luminal Na+ influx. The Na,K-ATPase
(Na+ pump) that coordinately extrudes Na+
across the basolateral membrane is known to be regulated by short term
aldosterone as well. We now show that in the cortical collecting duct
(CCD) from adrenalectomized rats, the increase in Na,K-ATPase activity (approximately 3-fold in 3 h), induced by a single
aldosterone injection, can be fully accounted by the increase in
Na,K-ATPase cell surface expression (+ 497 ± 35%). The short
term aldosterone action was further investigated in cultured mouse
collecting duct principal cells mpkCCDcl4. Within 2 h,
maximal Na,K-ATPase function assessed by Na+ pump current
(Ip) measurements and Na,K-ATPase cell surface
expression were increased by 20-50%. Aldosterone did not modify the
Na+ dependence of the Na+ pumps and induced
transcription- and translation-dependent actions on pump
surface expression and current independently of ENaC-mediated Na+ influx. In summary, short term aldosterone directly
increases the cell surface expression of pre-existing Na+
pumps in kidney CCD target cells. Thus, aldosterone controls Na+ reabsorption in the short term not only by regulating
the apical cell surface expression of ENaC (Loffing, J., Zecevic, M.,
Feraille, E., Kaissling, B., Asher, C., Rossier, B. C., Firestone,
G. L., Pearce, D., and Verrey, F. (2001) Am. J. Physiol. 280, F675-F682) but also by coordinately acting on the
basolateral cell surface expression of the Na,K-ATPase.
 |
INTRODUCTION |
The mineralocorticoid hormone aldosterone plays a central role in
the regulatory network that controls body sodium and volume homeostasis
(1). It displays a potent Na+ retaining action at the level
of tight epithelia, in particular in the aldosterone-sensitive
distal nephron (ASDN),1 a
portion of the kidney tubule that extends from the second part of the
distal convoluted tubule to the medullary collecting duct (2-4). The
segment-specific cells of the ASDN express a transcellular pathway for
Na+ reabsorption that is composed of the luminal epithelial
Na+ channel (ENaC) and the basolateral Na,K-ATPase
(Na+ pump). The activity of this Na+
reabsorptive pathway is controlled by aldosterone mostly via the mineralocorticoid receptor and to some extent also via
the glucocorticoid receptor (5-8). To prevent these nuclear
corticosteroid receptors from being activated by glucocorticoids, the
ASDN cells express the 11 -hydroxysteroid dehydrogenase type 2, which
metabolizes glucocorticoids (9).
The transcription- and translation-dependent action of
aldosterone on Na+ transport starts progressively after a
lag period of ~30 min in adrenalectomized rats and amphibian model
epithelia (10-12). This action has been schematically divided into an
early regulatory phase (lasting 2-4 h after the lag period) and a late
anabolic phase (12). The early, short term action of aldosterone is
considered to be largely mediated by induced regulatory proteins, such
as the serum- and glucocorticoid-inducible protein kinase, that are thought to act on the pre-existing Na+ transport machinery
(13-15).
The action of aldosterone on Na+ transport at the level of
ASDN cells is pleiotropic. For instance, aldosterone is known to act on
both major Na+ transport proteins, apical ENaC, and the
basolateral Na,K-ATPase (1, 16). As regards the mechanism by which ENaC
is regulated, a recent study has shown that a single aldosterone
injection given to adrenalectomized (ADX) rats induces the synthesis of
new ENaC -subunits and, in the early ASDN, the translocation of ,
, ENaC to the apical cell surface as well (4).
Concerning the effect of aldosterone on the Na,K-ATPase, measurements
performed two decades ago on cortical collecting ducts (CCD) of
adrenalectomized rats have shown that aldosterone restores within 1-3
h the Na,K-ATPase hydrolytic activity Vmax
and/or the number of ouabain binding sites (17-21). The nature of this
effect was not known because the data could not distinguish between the possibilities that additional Na+ pump units are
synthesized, that Na+ pumps are activated in
situ, or that Na+ pumps are recruited/translocated
from an intracellular pool to the cell surface.
The aim of the present study was to characterize the mechanism of the
short term aldosterone effect on Na,K-ATPase activity in the mammalian
ASDN. We first demonstrated in isolated CCDs of ADX rats that the
regulatory effect of aldosterone on Na,K-ATPase activity could be
accounted for by the regulation of the cell surface expression of the
Na,K-ATPase. Because a qualitatively similar effect of aldosterone was
detected in the mouse collecting duct principal cell line
mpkCCDcl4 (22), this cell line proved to be a useful
in vitro model for further investigations.
 |
EXPERIMENTAL PROCEDURES |
Experimental Model and Isolated Rat Kidney Tubules--
Male
Wistar rats (Charles River Laboratories, Saint Germain de l'Arbresle,
France) weighting 120-130 g were adrenalectomized under isoflurane
anesthesia and had then free access to a 0.9% NaCl solution for 1 week. A single dose of aldosterone (10 µg/kg) was infused
intravenously in 0.3 ml of 0.9% NaCl, whereas controls received
diluent. 3 h later, the rats were anesthetized with pentobarbital (5 mg/100 g of body weight, given intraperitoneally), the left kidney
was infused with incubation solution, and single CCDs were isolated by
microdissection in ice-cold oxygenated incubation solution (120 mM NaCl, 5 mM KCl, 4 mM
NaHCO3, 1 mM CaCl2, 1 mM MgSO4, 0.2 mM
NaH2PO4, 0.15 mM
Na2HPO4, 5 mM glucose, 10 mM lactate, 1 mM pyruvate, 4 mM
essential and nonessential amino acids, 0.03 mM vitamins,
20 mM HEPES, 0.1% (w/v) bovine serum albumin, pH 7.45)
containing aprotinin (10 millitrypsin-inhibitor units/ml) and
leupeptin (20 mg/ml) as described (23). The length of tubular segments
that served as reference for Na,K-ATPase activities and Western blot
analysis was determined from the photographs of microdissected CCDs.
Cell Culture--
mpkCCDcl4 cells (passages 18-40)
were cultured as described in Ref. 22. For filter cultures, the cells
were seeded at high density on Transwell filters (Costar) and kept for
6-8 days in standard medium. 24 h prior to the experiments,
epithelia were placed into serum- and hormone-deprived medium. To
obtain maximal effects that are mediated via the
mineralocorticoid and the glucocorticoid receptors, aldosterone was
used at 10 6 M (5-8).
Measurement of Na,K-ATPase Activity--
The hydrolytic activity
of the Na,K-ATPase was determined under Vmax
conditions by the release of Pi from
[ -32P]ATP on isolated rat CCDs permeabilized by
freeze/thawing, as previously described (24). This permeabilization
procedure has been shown to reveal a pool of Na,K-ATPase that
correlates with the cell surface expressed Na+ pumps (23).
The Na,K-ATPase activity was measured on quadruplicate samples of four
to six CCDs and taken as the difference between the mean ATPase
activities in the absence (150 mM choline chloride, 2 mM ouabain) or presence of Na+ and
K+ (100 mM NaCl and 5 mM KCl). The
results are expressed as pmol ATP × mm 1 × h 1.
Measurement of the Ouabain-sensitive
86Rb+ Uptake--
The cation transport
activity of Na,K-ATPase was measured as ouabain-sensitive
86Rb+ uptake under conditions of initial rate
on mpkCCDcl4 epithelia grown on 12-mm diameter Transwell
filters. Incubations with aldosterone and/or drugs were for the
indicated times in serum- and hormone-deprived medium (see above). The
transport activity of Na,K-ATPase was determined, as previously
described (23), in quadruplicate samples following a preincubation of
30 min in the presence or absence of 2 mM ouabain. Protein
content was determined in parallel by using the BCA assay (Pierce). The
ouabain-sensitive 86Rb+ uptake was calculated
as the difference between the mean values with or without 2 mM ouabain, and the results are expressed as pmol
Rb+ × µg protein 1 × min 1.
Electrophysiology--
The equivalent short circuit current was
calculated according to Ohm's law from the values of transepithelial
potential difference and resistance measured with a Millicell
(Millipore) device. Na+ pump current
(Ip) was measured as previously described (25). Confluent mpkCCDcl4 cells grown on Transwell filters (24-mm
diameter) were transferred for 3 h to HEPES-buffered Dulbecco's
modified Eagle's medium and kept under air atmosphere at 37 °C. The
cell layers were then permeabilized apically to monovalent ions with 35 µg/ml amphotericin B for 15 min at 37 °C in Na+-free
buffer containing 116 mM K+ gluconate, 1.8 mM CaCl2, 1.6 mM MgCl2,
0.8 mM KH2PO4, 2 mM
D-glucose, 12 mM essential amino acids, 2 mM nonessential amino acids, 0.4 mM glutamine,
25 mM HEPES, 3 mM Ba(OH)2 and
adjusted to pH 7.4 with Tris. The filters were then transferred to a
Ussing chamber, and Na+ was added to the desired final
concentration by mixing Na+ buffer (Na+ replacement of
K+) with the Na+-free buffer. Measurements were
done under short circuit conditions before and after the addition of 1 mM ouabain to the basolateral compartment, and the
Ip was calculated as the difference between the
total and the ouabain-resistant current. For estimating
Vmax and the Na+ concentration
required for half-maximal activation (K0.5), the Ip max of the control epithelia was
estimated for each experiment by fitting a sigmoidal curve with a
nonlinear regression analysis routine (Prism, GraphPad) to the data,
using a Hill coefficient fixed at 2.3 (26). After normalization with
the Ip max of the controls, the data were
pooled, and the mean Ks0.5 was determined.
Measurement of Total and Cell Surface Expression of the
Na,K-ATPase -Subunit--
The solubilization of proteins from 100 microdissected isolated CCDs (0.2-0.5-mm length) and Western blotting
were performed as previously described (23). Proteins were blotted onto
a polyvinylidine difluoride membrane (Immobilon-P, Millipore),
incubated overnight with a polyclonal antibody (dilution, 1:2500)
raised against the -subunit of Na,K-ATPase (27), and then incubated
with a second anti-rabbit IgG antibody (dilution, 1:10000) coupled to
horseradish peroxidase (Transduction Laboratories, Lexington, KY).
Detection was performed by chemiluminescence using the Super Signal
substrate method (Pierce).
Measurement of cell surface Na,K-ATPase was performed on isolated rat
CCDs as described (23) using EZ-Link sulfossuccinimidobiotin (Sulfo
NHS-S-S-Biotin; Pierce) for labeling of cell surface proteins. Biotinylated proteins were precipitated with streptavidin-agarose beads
(Immunopure immobilized streptavidin; Pierce). In the present case, the
beads were then washed three times with anti-protease-containing buffer
(50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 5 mM EDTA, 20 µg/ml leupeptin, 10 millitrypsin-inhibitor units/ml aprotinin) and once with 10 mM Tris-HCl, pH 7.4. Solubilization of the precipitated proteins, SDS-PAGE, and Western blotting were as described above. The
amounts of proteins loaded on each lane corresponded to the same
initial length of isolated CCDs (± 5%). The chemiluminescence signals
were quantified by densitometry and expressed in each experiment as
percentages of the control. The results are expressed as the means ± S.E. from several animals.
For mpkCCDcl4 epithelia grown on Transwell filters (12-mm
diameter), a similar procedure was used for cell surface biotinylation, streptavidin-agarose precipitation, and Western blotting (23). The
protein concentration of the lysates was measured with the BCA protein
assay (Pierce) to load equal amounts of proteins on each lane for
Western blotting and to submit equal amounts of proteins to
streptavidin-agarose precipitation.
Statistics--
Statistical analysis of Na,K-ATPase activities,
86Rb+ uptakes and Ip were done by
unpaired Student t test or by analysis of variance for
comparison of two or more than two groups, respectively. Statistical analysis of Na,K-ATPase -subunit immunoreactivity was done using the
Mann-Whitney U test or the Kruskal-Wallis test for
comparison of two or more than two groups, respectively. The results
are expressed as the means ± S.E. from n independent
experiments. Each experiment was performed with tubules from one animal
or with cells from one passage. A p value less < 0.05 was considered significant.
 |
RESULTS |
Short Term Aldosterone Increases in Vivo Na,K-ATPase Hydrolytic
Activity and Cell Surface Expression in Intact Rat Cortical Collecting
Duct--
The effect of a single intravenous infusion of aldosterone
on Na,K-ATPase activity and expression was investigated in CCDs of ADX
rats. As reported earlier (17-19), short term aldosterone (3 h)
increased the maximal hydrolytic activity of the Na,K-ATPase by
~200% (ADX control, 323 ± 80; ADX aldosterone, 940 ± 150 pmol ATP × mm 1 × h 1;
n = 9; p < 0.01). We performed Western
blotting to test whether or not this increase in enzyme activity could
be explained by an increase in the cellular pool of the Na,K-ATPase. As
shown in Fig. 1B, this did not
appear to be the case because the -subunit pool was increased only
by 63 ± 7% (n = 8), and the -subunit was
increased similarly by 71 ± 21% (n = 8; data not
shown). To test the hypothesis that it was mainly the cell surface pool
of the Na,K-ATPase that was increased by the short aldosterone
treatment, we performed cell surface biotinylation followed by
precipitation with streptavidin-agarose beads and Western blotting.
Fig. 1C shows that aldosterone increased the amounts of cell
surface Na,K-ATPase -subunit by 497 ± 35% (n = 8). Thus, the increase in maximal Na,K-ATPase hydrolytic activity
observed in CCDs of adrenalectomized rats 3 h after a single
aldosterone injection appears to be entirely mediated by an increase in
its cell surface expression.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of aldosterone (single injection,
3 h) on Na,K-ATPase hydrolytic activity
(Vmax), and on the Na,K-ATPase
-subunit total and cell surface pools in CCDs of
adrenalectomized rats. A, effect of aldosterone on
Na,K-ATPase activity. The activity was determined in
Vmax conditions on freeze/thawing permeabilized
CCDs of control (Ctl) and aldosterone-injected
(Ald) rats. The results, expressed as percentages of
controls, are the means ± S.E. from nine separate experiments.
**, p < 0.01. B, effect of aldosterone on
the total Na,K-ATPase -subunit pool detected by Western blotting.
Bands from a representative immunoblot are shown in the upper
panel (two different samples for control and aldosterone (3 h)),
and the bars in the lower panel represent the
densitometric quantification values, expressed as percentages of
control, from six independent experiments. *, p < 0.05. C, effect of aldosterone on the cell surface
expression of the Na,K-ATPase -subunit. Cell surface proteins from
microdissected CCDs were biotinylated, solubilized, and precipitated by
streptavidin-agarose beads, and the Na,K-ATPase -subunit was
detected by Western blotting. A representative immunoblot (two
different samples for control and aldosterone (3 h)) is shown in the
upper panel, and the bars in the lower
panel represent the densitometric quantification values, expressed
as percentages of control, from seven independent experiments. **,
p < 0.01.
|
|
Short Term Aldosterone Increases in Vitro the Function of
Na,K-ATPase in Cultured mpkCCDcl4 Cells--
We used the
ex vivo CCD model of cultured mpkCCDcl4 cells
grown on filter supports to characterize more extensively the mechanism underlying the short term effect of aldosterone. This cell line was
derived from mouse CCD and was shown to express an
aldosterone-inducible amiloride-sensitive electrogenic
Na+ transport (22). As expected, 1 µM
aldosterone increased the transepithelial short circuit current
(Isc) already within 1 h and further during
the second hour of treatment (Fig. 2).
The transport activity of the Na,K-ATPase (Na+ pump),
measured as 86Rb+ uptake, increased in response
to aldosterone with a time course close to the
Isc (Fig. 2).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 2.
Time course of aldosterone action on the
transepithelial current, ouabain-sensitive
86Rb+ uptake and pump current in
mpkCCDcl4 cells. Confluent mpkCCDcl4 cells
grown of polycarbonate filters were incubated in the absence or
presence of 1 µM aldosterone. The transepithelial
equivalent short circuit current (Isc)
(triangles, n = 17), the ouabain-sensitive
86Rb+ uptake (circles,
n = 6) and the Na+ pump current
(Ip) (diamonds, n = 4-6) are expressed as percentages of control (means ± S.E.). All
test values were significantly different from their control
(p < 0.05).
|
|
Because the 86Rb+ uptake assay does not
discriminate between kinetic activation of the Na+ pump by
intracellular Na+ concentration
([Na+]i) versus regulatory changes in
pump number or activity, ouabain-sensitive pump currents were measured.
The apical membrane of the epithelia was selectively permeabilized to
monovalent cations with amphotericin B, thus allowing the control of
[Na+]i. Under these experimental conditions,
aldosterone increased the current carried by the Na+ pump
by ~30%, following during the first 2 h a similar time course as the increase in transepithelial Isc (Fig. 2).
Na+ activation experiments were then performed to determine
whether this regulatory effect of aldosterone on Na,K-ATPase function corresponded to a change in Na+ affinity or to an increase
in the maximal transport capacity of the basolateral Na+
pumps. Fig. 3 shows that the apparent
affinity for Na+ was not changed by aldosterone
(K0.5 control, 8.5 mM;
K0.5 aldosterone, 10.1 mM;
n = 4; difference not significant). Similar to
the observations made in rat CCDs (Fig. 1), these results suggested
that the effect of aldosterone might correspond to an increase in the
number of functional Na+ pumps at the basolateral
membrane.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 3.
Aldosterone increases the Na+
pump current (Ip) without modifying the
apparent Na+ affinity of the Na+ pumps in
mpkCCDcl4 epithelia. Confluent
mpkCCDcl4 cells grown on filters were incubated in the
absence (empty circles) or in the presence (filled
circles) of 1 µM aldosterone for 2 h. The
Ip was measured at various Na+
concentrations after permeabilization of the apical membrane to
monovalent ions with amphotericin B. The results, expressed as
percentages of control Ip max are the
means ± S.E. from four independent experiments. *,
p < 0.05. Sigmoidal dose-response curves were fitted
to the experimental points using a Hill coefficient fixed at 2.3 (26).
Derived K0.5 values (8.5 and 10.1 mM, for control and aldosterone, respectively) were not
significantly different.
|
|
In summary, the results shown in Figs. 2 and 3 confirmed that short
term aldosterone increases the electrogenic transepithelial sodium
transport in cultured mpkCCDcl4 cells. Furthermore, they showed that this effect not only reflects an increase in apical Na+ influx via ENaC and a consecutive kinetic
activation of the Na,K-ATPase but also reflects a regulatory change in
the maximal Na,K-ATPase function.
Aldosterone Increases the Cell Surface Expression of the
Na,K-ATPase -Subunit in Cultured mpkCCDcl4-
Cells--
To test whether the effect of aldosterone on the pump
function of mpkCCDcl4 cells was due to an increase in
Na,K-ATPase cell surface expression, we performed cell surface
biotinylations followed by streptavidin-agarose precipitation and
Western blotting. Fig. 4A
shows that 1 µM aldosterone time-dependently
increased the cell surface amount of the Na,K-ATPase -subunit. This
effect was statistically significant after 2 h and, up to that
time point, quantitatively similar to the increase in
Ip. The cell surface expression continued to
increase at later time points and reached a maximum after 6 h
(increase by 60 ± 5.2%; n = 6; p < 0.05), whereas the IP remained approximately
at the same level (compare Figs. 2 and 4A). Western blotting
on total cell extracts showed that the total pool of Na,K-ATPase
-subunit increased as well but later than the surface expression and
to a lesser extent, reaching a maximum at 24 h (increase by
38 ± 8.5; n = 8; p < 0.05) (Fig.
4B).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 4.
Time course of aldosterone action on whole
cell and cell surface Na,K-ATPase subunit in
cultured mpkCCDcl4 cells. Confluent
mpkCCDcl4 cells grown on filters were incubated in the
absence (Ctl) or presence of 1 µM aldosterone.
A, effect of aldosterone on cell surface expression of the
Na,K-ATPase -subunit. After cell surface protein biotinylation and
streptavidin-agarose precipitation, the surface-expressed Na,K-ATPase
-subunit was detected by Western blotting. The bands from
a representative immunoblot are shown (upper panel). The
bars (lower panel) represent the densitometric
quantification (percentages of control, means ± S.E.) from six
independent experiments. *, p < 0.05. B,
effect of aldosterone on the total Na,K-ATPase -subunit pool. The
-subunit was detected by Western blotting. The bands from
a representative immunoblot are shown (upper panel). The
bars (lower panel) represent the densitometric
quantification (percentage of control, means ± S.E.) from six
independent experiments. *, p < 0.05.
|
|
The correlation of the early aldosterone-induced increase in cell
surface Na,K-ATPase ( 2 h) (Fig. 4A) with the increase in Ip (Fig. 2) suggests that the latter effect on
Ip might result from the increase in
Na+ pump cell surface expression. Although less pronounced,
these results are qualitatively similar to those obtained in intact rat
CCDs (Fig. 1). Thus, mpkCCDcl4 cells appear to be a
suitable model to study the mechanism of collecting duct Na,K-ATPase regulation.
Aldosterone Stimulates Na,K-ATPase Activity by a
Transcription-dependent Mechanism That Is Independent of the
Apical Na+Entry--
Aldosterone stimulates the expression
and activity of the ENaC and thus the apical influx of Na+
in mkpCCDcl4 cells (22). Therefore, the increase in
Na+ pump function that appears to be mediated by an
increase in Na,K-ATPase cell surface expression could have been
secondary to an increase in [Na+]i. To test this
possibility, we prevented the apical Na+ influx during the
aldosterone treatment with the ENaC inhibitor amiloride. As shown by
the 86Rb+ uptake experiments (performed after
washout of amiloride for 5 min), the cellular transport response to
aldosterone remained unchanged (Fig. 5).
Importantly, the regulation of the Na,K-ATPase measured by the
Ip and the increase in Na,K-ATPase cell surface expression were maintained as well, indicating that the early effect of
aldosterone at the level of the Na+ pump is not secondary
to apical Na+ entry.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Amiloride does not prevent the stimulation of
ouabain-sensitive 86Rb+ uptake,
Ip, and Na,K-ATPase cell surface
expression by aldosterone in cultured mpkCCDcl4 cells.
Cells grown on filters were incubated in the absence or presence of 1 µM aldosterone and/or 1 µM amiloride for 2 or 3 h at 37 °C. The bars represent percentages of
controls. A, effect of amiloride on the aldosterone-induced
(2 h) stimulation of ouabain-sensitive 86Rb+
uptake. B, effect of amiloride on the aldosterone-induced (2 h) stimulation of Ip. C,
effect of amiloride on the aldosterone-induced (3 h) increase in
Na,K-ATPase cell surface expression. The results are the means ± S.E. from six (A), three (B), and seven
(C) separate experiments. *, p < 0.05 versus control.
|
|
We next tested whether the effect of aldosterone on Na+
transport depends in cultured mpkCCDcl4 cells on ongoing
transcription and translation, as previously reported for intact rat
CCDs (21) and amphibian epithelia (28). Actinomycin D (5 µM) or cycloheximide (20 µM) was added to
prevent transcription or translation, respectively, during the
aldosterone treatment. Both inhibitors blocked the effect of
aldosterone on the 86Rb+ uptake and also
slightly decreased the base-line transport in untreated
mpkCCDcl4 cells (Fig. 6,
A and C). This showed that the transepithelial
Na+ transport and, in particular, its stimulation by
aldosterone depend on ongoing transcription and translation in
mpkCCDcl4 cells as well. Similarly, the aldosterone-induced
increase in Na,K-ATPase cell surface expression and activation of the
Na+ pump function measured as Ip
were also fully prevented by cycloheximide and actinomycin D,
respectively (Fig. 6, B and D). Thus, the
increase in basolateral Na+ pump function induced by
aldosterone requires, similar to the stimulation of transepithelial
Na+ transport, a functional transcription and translation
machinery.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 6.
Transcriptional and translational dependence
of the effect of aldosterone on Na,K-ATPase surface expression and
Ip in cultured mpkCCD
cells. Cells grown on filters were incubated in the absence or
presence of 1 µM aldosterone and/or 2 µM
cycloheximide (A and B) or 5 µM
actinomycin D (C and D) for 2 or 3 h at
37 °C. A, effect of cycloheximide on the
aldosterone-induced (2 h) stimulation of ouabain-sensitive
86Rb+ uptake. B, effect of
cycloheximide on the aldosterone-induced (3 h) increase in Na,K-ATPase
cell surface expression. C, effect of actinomycin D on the
aldosterone-induced stimulation of ouabain-sensitive
86Rb+ uptake. D, effect of
actinomycin D on the aldosterone-induced stimulation of
Ip. The results, expressed as percentages of
control values, are the means ± S.E. from five (A and
C), eight (B), and three (D) separate
experiments. *, p < 0.05 versus control.
p < 0.05 versus control.
|
|
 |
DISCUSSION |
Role of Na+ Pump Regulation by Short Term Aldosterone
in CCD Cells--
The present study shows that short term aldosterone
increases the maximal activity of the Na,K-ATPase in mammalian cortical collecting duct cells by increasing its cell surface expression. This
finding seemingly opposes the current understanding that the single
rate-limiting site of Na+ transport regulation by
aldosterone is ENaC, at least in the short term.
Because the Na,K-ATPase activity (the actual pumping rate) strongly
depends on [Na+]i (positive cooperativity with
Hill coefficient between 2 and 3) (16, 25, 29-31) and because
[Na+]i is generally below its half-maximal
activation concentration (K0.5) in CCD (30, 31),
it has been suggested that the kinetic control of the pump function
would suffice to match the basolateral efflux of Na+ to its
luminal influx. However, a lack of Na,K-ATPase regulation would lead to
fluctuations in [Na+]i that would tend to blunt
the transport response because the Na+ flux through ENaC
activity strongly depends on [Na+]i (32). For
instance, the electrochemical driving force for Na+ influx
via ENaC depends on [Na+]i (33). This
is particularly relevant in the collecting duct where luminal/urinary
Na+ concentration can be quite low. Second, high
[Na+]i exerts a strong negative feedback
regulation on ENaC function (33, 34). Furthermore, a coordinated
regulation of the Na+ pumps might also be important in the
collecting duct, because this part of the nephron expresses
Na+ pumps with a high apparent affinity for Na+
(31). Thus, the Na+ pumps of the CCD have, at a given
[Na+]i, less kinetic reserve than Na+
pumps with a lower apparent affinity. Taken together, it is not surprising that the regulation of transepithelial Na+
transport by aldosterone relies, besides on the regulation of ENaC,
also on the regulation of the Na+ pumps, as demonstrated in
this study.
The extent by which aldosterone stimulates the maximal Na+
pump current (independent of [Na+]i) in
mpkCCDcl4 epithelia (20-50% after 2 h) represents approximately half of the effect aldosterone exerts on the
ouabain-sensitive 86Rb+ uptake (40-100% after
2 h). Because this latter assay measures the actual pumping rate
of the Na,K-ATPase and because the apparent Na+ affinity of
the Na,K-ATPase is not altered by aldosterone (Fig. 3), this indicates
that approximately half of the Na+ pump activation measured
by 86Rb+ uptake must result from a kinetic
activation of Na+ pumps, presumably in response to an
increase in [Na+]i that is secondary to the
increase in apical Na+ influx. Hence, it appears that in
our experimental conditions the increase in transcellular
Na+ transport observed in mpkCCDcl4 cells is
supported, at the basolateral membrane, in part by an increase in the
number of active pumps and that the other part relies on the kinetic
activation of the Na+ pumps.
Pathway Leading to Aldosterone-induced Na,K-ATPase Cell Surface
Expression--
Blocking ENaC function during the aldosterone
treatment with a low amiloride concentration did not prevent the
aldosterone-induced increase in Na+ pump surface expression
and Na+ pump current. Thus, these effects are not secondary
to an increase in apical Na+ influx. They may rather be
mediated by (an) aldosterone-induced regulatory protein(s) that
directly trigger(s) the redistribution of Na,K-ATPase toward the
basolateral membrane. It remains to be investigated whether
aldosterone-induced serum and glucocorticoid-induced kinase 1, which
appears to play a major role in the control of ENaC cell surface
expression (4, 36), also plays such a role for the control of
Na,K-ATPase cell surface expression.
Previous reports have suggested that aldosterone determines in rat CCD
the existence of a pool of inactive Na+ pumps that can be
recruited/activated in response to cAMP or cell volume increase (37,
38). The present study shows that aldosterone-deprived CCD cells
(ADX rats) contain nonetheless a large pool of inactive Na+
pumps that can be recruited by aldosterone. Thus, one can speculate that CCD cells lack, in the absence of aldosterone, (a) gene product(s) other than the Na+ pump that is(are) required to allow
physiological stimuli such as cAMP and volume increase to
recruit/activate Na+ pumps.
Interestingly, the cAMP-induced recruitment/activation of
Na+ pumps in CCDs has been recently shown to be mediated by
the redistribution of Na+ pumps to the cell surface,
similar to the short term effect of aldosterone described in the
present study (23). Thus, it will be interesting to clarify the
relationship between the mechanisms involved in the aldosterone- and
the cAMP-induced Na+ pump translocation events.
The late effect of aldosterone that leads to an increase in the
cellular Na+ pump pool of CCD (39) was also observed in
mpkCCDcl4 cells in the present study. This late increase in
the Na+ pump pool is parallel to the late part of the
increase in Na+ pump cell surface expression (later than 2 h after aldosterone addition) and can therefore fully account
for it. Interestingly, the recently described effect of
puromycin-induced nephrotic syndrome on Na,K-ATPase expression in the
CCD resembles the late effect of aldosterone described here (40).
Unlike the Na,K-ATPase cell surface expression, the
Ip did not increase between 2 and 6 h after
aldosterone addition. We hypothesize that this lack of correlation
might be the result of other regulatory effects that modulated the
activity of pumps expressed at the cell surface (16). It is noteworthy
to mention that, similarly, the increase in Na,K-ATPase cell surface
expression measured in CCDs (~6-fold) was larger than the
corresponding increase in Na,K-ATPase activity (3-fold), also
suggesting the possibility of an in situ counterregulation.
Lack of Short Term Change in Apparent Na+
Affinity--
The short term effect of aldosterone on Na,K-ATPase
Vmax, i.e. on its cell surface
expression, that we have observed in mammalian CCD and
mpkCCDcl4 cells, is clearly different from the effect previously observed in amphibian A6 cells. In this latter model, short
term aldosterone appeared to increase the Na+ affinity of a
subpopulation of Na+ pumps and had no measurable effect on
the Na,K-ATPase cell surface expression (25, 41). However, recent
reports on the expression of CHIF and its interaction with the
Na,K-ATPase suggest that aldosterone may act in the long term on the
apparent Na+ affinity of Na+ pumps in mammalian
collecting duct as well. Indeed, CHIF was shown to be expressed in the
medullary collecting ducts of rats, to be up-regulated in the kidney by
low salt diet (high aldosterone), and to associate with coexpressed
Na,K-ATPase in Xenopus oocytes, thereby increasing its
apparent affinity for [Na+]i (35, 42). Such a
long term effect of aldosterone on the apparent intracellular
Na+ affinity of Na+ pumps would increase the
driving force for apical Na+ entry via ENaC.
Thus, we can hypothesize that aldosterone increases the driving force
for Na+ entry via synergistic mechanisms: 1) as
shown in this study, by increasing the amount of cell surface expressed
Na+ pumps, in the short term by a translocation mechanism
and in the long term by increasing the Na+ pump cellular
pool and 2) by increasing the apparent affinity of Na+
pumps for [Na+]i. Some axial heterogeneity of
this putative effect can be anticipated, because increasing the driving
force for apical Na+ entry via ENaC is
physiologically most relevant for distal portions of the ASDN where
maximal Na+ retention leads to very low luminal
Na+ concentrations.
In conclusion, aldosterone exerts, already in the short term, a
pleiotropic action on the transcellular Na+ reabsorption
machinery of CCD cells. Besides regulating the luminal influx of
Na+ at the level of ENaC, it also controls the surface
expression of Na+ pumps. This mechanism should prevent an
excessive increase in [Na+]i that otherwise would
exert a negative feedback on the apical Na+ influx
via ENaC. Thus, Na,K-ATPase regulation contributes to the
short term control of transepithelial Na+ transport by aldosterone.
 |
ACKNOWLEDGEMENTS |
We thank Martine Rousselot for technical
assistance and Christian Gasser for artwork.
 |
FOOTNOTES |
*
This work was supported by Swiss National Science Foundation
Grants 31-59141.99 (to F. V.) and 31-50830.99 (to E. F.), by the Hartmann-Müller Stiftung in Zürich, and by the Carlos
and Elsie de Reuter Foundation in Geneva.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
**
To whom correspondence should be addressed: Inst. of Physiology,
University of Zürich, Winterthurerstrasse 190, CH-8057
Zürich, Switzerland. Tel.: 41-1-635-5044; Fax:
41-1-635-6814; E-mail: verrey@physiol.unizh.ch.
Published, JBC Papers in Press, October 11, 2001, DOI 10.1074/jbc.M107165200
 |
ABBREVIATIONS |
The abbreviations used are:
ASDN, aldosterone-sensitive distal nephron;
ENaC, epithelial sodium channel;
CCD, cortical collecting duct;
ADX, adrenalectomized.
 |
REFERENCES |
| 1.
|
Verrey, F.,
Hummler, E.,
Schild, L.,
and Rossier, B. C.
(2000)
in
The Kidney: Physiology and Pathophysiology
(Seldin, D. W.
, and Giebiesch, G., eds), 3rd Ed.
, pp. 1441-1471, Lippincott, Williams & Wilkins, Philadelphia, PA
|
| 2.
|
Bachmann, S.,
Bostanjoglo, M.,
Schmitt, R.,
and Ellison, D. H.
(1999)
Anat. Embryol.
200,
447-468[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Reilly, R. F.,
and Ellison, D. H.
(2000)
Physiol. Rev.
80,
277-313[Abstract/Free Full Text]
|
| 4.
|
Loffing, J.,
Zecevic, M.,
Feraille, E.,
Kaissling, B.,
Asher, C.,
Rossier, B. C.,
Firestone, G. L.,
Pearce, D.,
and Verrey, F.
(2001)
Am. J. Physiol.
280,
F675-F682
|
| 5.
|
Geering, K.,
Claire, M.,
Gaeggeler, H. P.,
and Rossier, B. C.
(1985)
Am. J. Physiol.
248,
C102-C108[Abstract/Free Full Text]
|
| 6.
|
Laplace, J. R.,
Husted, R. F.,
and Stokes, J. B.
(1992)
J. Clin. Invest.
90,
1370-1378
|
| 7.
|
Garty, H.,
Peterson-Yantorno, K.,
Asher, C.,
and Civan, M. M.
(1994)
Am. J. Physiol.
266,
F108-F116[Abstract/Free Full Text]
|
| 8.
|
Berger, S.,
Bleich, M.,
Schmid, W.,
Greger, R.,
and Schutz, G.
(2000)
Kidney Int.
57,
1295-1298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Funder, J. W.,
Pearce, P. T.,
Smith, R.,
and Smith, A. I.
(1988)
Science
242,
583-585[Abstract/Free Full Text]
|
| 10.
|
Horisberger, J. D.,
and Diezi, J.
(1983)
Am. J. Physiol.
245,
F89-F99[Abstract/Free Full Text]
|
| 11.
|
El Mernissi, G.,
and Doucet, A.
(1983)
Pflueger's Arch. Eur. J. Physiol.
339,
139-146
|
| 12.
|
Verrey, F.
(1995)
J. Membr. Biol.
144,
93-110[Medline]
[Order article via Infotrieve]
|
| 13.
|
Chen, S.,
Bhargava, A.,
Mastroberardino, L.,
Meijer, O. C.,
Wang, J.,
Buse, P.,
Firestone, G. L.,
Verrey, F.,
and Pearce, D.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2514-2519[Abstract/Free Full Text]
|
| 14.
|
Naray-Fejes-Toth, A.,
Canessa, C.,
Cleaveland, E. S.,
Aldrich, G.,
and Fejes-Toth, G.
(1999)
J. Biol. Chem.
274,
16973-16978[Abstract/Free Full Text]
|
| 15.
|
Loffing, J.,
Summa, V.,
Zecevic, M.,
and Verrey, F.
(2001)
Curr. Opin. Nephrol. Hypertens.
10,
667-675[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Feraille, E.,
and Doucet, A.
(2001)
Physiol. Rev.
81,
345-418[Abstract/Free Full Text]
|
| 17.
|
Horster, M.,
Schnid, H.,
and Schmidt, U.
(1980)
Pfluegers Arch. Eur. J. Physiol.
384,
203-206[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Petty, K. J.,
Kokkoi, J. P.,
and Marver, D.
(1981)
J. Clin. Invest.
68,
1514-1521
|
| 19.
|
El Mernissi, G.,
and Doucet, A.
(1983)
Pfluegers Arch. Eur. J. Physiol.
399,
147-151[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
El Mernissi, G.,
and Doucet, A.
(1984)
Pfluegers Arch. Eur. J. Physiol.
402,
258-263[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Barlet-Bas, C.,
Khadoury, C.,
Marsy, S.,
and Doucet, A.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
1707-1711[Abstract/Free Full Text]
|
| 22.
|
Bens, M.,
Vallet, V.,
Cluzeaud, F.,
Pascual-Letallec, L.,
Kahn, A.,
Rafestin-Oblin, M. E.,
Rossier, B. C.,
and Vandewalle, A.
(1999)
J. Am. Soc. Nephrol.
10,
923-934[Abstract/Free Full Text]
|
| 23.
|
Gonin, S.,
Deschenes, G.,
Roger, F.,
Bens, M.,
Martin, P. Y.,
Carpentier, J. L.,
Vandewalle, A.,
Doucet, A.,
and Feraille, E.
(2001)
Mol. Biol. Cell
12,
255-264[Abstract/Free Full Text]
|
| 24.
|
Deschenes, G.,
and Doucet, A.
(2000)
J. Am. Soc. Nephrol.
11,
604-615[Abstract/Free Full Text]
|
| 25.
|
Beron, J.,
Mastroberardino, L.,
Spillmann, A.,
and Verrey, F.
(1995)
Mol. Biol. Cell
6,
261-271[Abstract]
|
| 26.
|
Pfeiffer, R.,
Beron, J.,
and Verrey, F.
(1999)
J. Physiol. (Lond.)
516,
647-655[Abstract/Free Full Text]
|
| 27.
|
Carranza, M. L.,
Feraille, E.,
and Favre, H.
(1996)
Am. J. Physiol.
271,
C136-C143[Abstract/Free Full Text]
|
| 28.
|
Verrey, F.,
Kraehenbuhl, J. P.,
and Rossier, B. C.
(1989)
Mol. Endocrinol.
3,
1369-1376[Abstract/Free Full Text]
|
| 29.
|
deWeer, P.
(1992)
in
The Kidney: Physiology and Pathophysiology
(Seldin, D. W.
, and Giebisch, G., eds), 2nd Ed.
, pp. 93-112, Raven Press, New York
|
| 30.
|
Blot-Chabaud, M.,
Jaisser, F.,
Gingold, M.,
Bonvalet, J. P.,
and Farman, N.
(1988)
Am. J. Physiol.
255,
F605-F613[Abstract/Free Full Text]
|
| 31.
|
Barlet-Bas, C.,
Cheval, L.,
Khadouri, C.,
Marsy, S.,
and Doucet, A.
(1990)
Am. J. Physiol.
259,
F246-F250[Abstract/Free Full Text]
|
| 32.
|
Schultz, S. G.
(1981)
Am. J. Physiol.
241,
F579-F590[Abstract/Free Full Text]
|
| 33.
|
Silver, R. B.,
Frindt, G.,
Windhager, E. E.,
and Palmer, L. G.
(1993)
Am. J. Physiol.
264,
F557-F564[Abstract/Free Full Text]
|
| 34.
|
Garty, H.,
and Palmer, L. G.
(1997)
Physiol. Rev.
77,
359-396[Abstract/Free Full Text]
|
| 35.
|
Beguin, P.,
Crambert, G.,
Guennoun, S.,
Garty, H.,
Horisberger, J.-D.,
and Geering, K.
(2001)
EMBO J.
20,
3993-4002[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Alvarez de la Rosa, D.,
Zhang, P.,
Naray-Fejes-Toth, A.,
Fejes-Toth, G.,
and Canessa, C. M.
(1999)
J. Biol. Chem.
274,
37834-37839[Abstract/Free Full Text]
|
| 37.
|
Blot-Chabaud, M.,
Wanstock, F.,
Bonvalet, J. P.,
and Farman, N.
(1990)
J. Biol. Chem.
265,
11676-11681[Abstract/Free Full Text]
|
| 38.
|
Barlet-Bas, C.,
Khadouri, C.,
Marsy, S.,
and Doucet, A.
(1990)
J. Biol. Chem.
265,
7799-7803[Abstract/Free Full Text]
|
| 39.
|
Welling, P. A.,
Caplan, M.,
Sutters, M.,
and Giebisch, G.
(1993)
J. Biol. Chem.
268,
23469-23476[Abstract/Free Full Text]
|
| 40.
| Deschenes, G., Gonin, S., Zolty, E., Cheval, L., Rousselot, M., Martin,
P. Y., Verbavatz, J.-M., Feraille, E., and Doucet, A. (2001)
J. Am. Soc. Nephrol., in press
|
| 41.
|
Beron, J.,
and Verrey, F.
(1994)
Am. J. Physiol.
266,
C1278-C1290[Abstract/Free Full Text]
|
| 42.
|
Shi, H.,
Levy-Holzman, R.,
Cluzeaud, F.,
Farman, N.,
and Garty, H.
(2001)
Am. J. Physiol.
280,
F505-F512[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B.-K. Liao, R.-D. Chen, and P.-P. Hwang
Expression regulation of Na+-K+-ATPase {alpha}1-subunit subtypes in zebrafish gill ionocytes
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2009;
296(6):
R1897 - R1906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Hasler
Controlled aquaporin-2 expression in the hypertonic environment
Am J Physiol Cell Physiol,
April 1, 2009;
296(4):
C641 - C653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Montesano, H. Ghzili, F. Carrozzino, B. C. Rossier, and E. Feraille
cAMP-dependent chloride secretion mediates tubule enlargement and cyst formation by cultured mammalian collecting duct cells
Am J Physiol Renal Physiol,
February 1, 2009;
296(2):
F446 - F457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. de Seigneux, V. Leroy, H. Ghzili, M. Rousselot, S. Nielsen, B. C. Rossier, P.-Y. Martin, and E. Feraille
NF-{kappa}B Inhibits Sodium Transport via Down-regulation of SGK1 in Renal Collecting Duct Principal Cells
J. Biol. Chem.,
September 12, 2008;
283(37):
25671 - 25681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schmidt, K. Hocherl, F. Schweda, A. Kurtz, and M. Bucher
Regulation of Renal Sodium Transporters during Severe Inflammation
J. Am. Soc. Nephrol.,
April 1, 2007;
18(4):
1072 - 1083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Fakitsas, G. Adam, D. Daidie, M. X. van Bemmelen, F. Fouladkou, A. Patrignani, U. Wagner, R. Warth, S. M.R. Camargo, O. Staub, et al.
Early Aldosterone-Induced Gene Product Regulates the Epithelial Sodium Channel by Deubiquitylation
J. Am. Soc. Nephrol.,
April 1, 2007;
18(4):
1084 - 1092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Good
Nongenomic Actions of Aldosterone on the Renal Tubule
Hypertension,
April 1, 2007;
49(4):
728 - 739.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Hasler, U. S. Jeon, J. A. Kim, D. Mordasini, H. M. Kwon, E. Feraille, and P.-Y. Martin
Tonicity-Responsive Enhancer Binding Protein Is an Essential Regulator of Aquaporin-2 Expression in Renal Collecting Duct Principal Cells
J. Am. Soc. Nephrol.,
June 1, 2006;
17(6):
1521 - 1531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lourdel, J. Loffing, G. Favre, M. Paulais, A. Nissant, P. Fakitsas, C. Creminon, E. Feraille, F. Verrey, J. Teulon, et al.
Hyperaldosteronemia and Activation of the Epithelial Sodium Channel Are Not Required for Sodium Retention in Puromycin-Induced Nephrosis
J. Am. Soc. Nephrol.,
December 1, 2005;
16(12):
3642 - 3650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mordasini, M. Bustamante, M. Rousselot, P.-Y. Martin, U. Hasler, and E. Feraille
Stimulation of Na+ transport by AVP is independent of PKA phosphorylation of the Na-K-ATPase in collecting duct principal cells
Am J Physiol Renal Physiol,
November 1, 2005;
289(5):
F1031 - F1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Hasler, M. Vinciguerra, A. Vandewalle, P.-Y. Martin, and E. Feraille
Dual Effects of Hypertonicity on Aquaporin-2 Expression in Cultured Renal Collecting Duct Principal Cells
J. Am. Soc. Nephrol.,
June 1, 2005;
16(6):
1571 - 1582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bustamante, U. Hasler, O. Kotova, A. V. Chibalin, D. Mordasini, M. Rousselot, A. Vandewalle, P.-Y. Martin, and E. Feraille
Insulin potentiates AVP-induced AQP2 expression in cultured renal collecting duct principal cells
Am J Physiol Renal Physiol,
February 1, 2005;
288(2):
F334 - F344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Naray-Fejes-Toth, P. M. Snyder, and G. Fejes-Toth
The kidney-specific WNK1 isoform is induced by aldosterone and stimulates epithelial sodium channel-mediated Na+ transport
PNAS,
December 14, 2004;
101(50):
17434 - 17439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Michlig, A. Mercier, A. Doucet, L. Schild, J.-D. Horisberger, B. C. Rossier, and D. Firsov
ERK1/2 Controls Na,K-ATPase Activity and Transepithelial Sodium Transport in the Principal Cell of the Cortical Collecting Duct of the Mouse Kidney
J. Biol. Chem.,
December 3, 2004;
279(49):
51002 - 51012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vinciguerra, S. Arnaudeau, D. Mordasini, M. Rousselot, M. Bens, A. Vandewalle, P.-Y. Martin, U. Hasler, and E. Feraille
Extracellular Hypotonicity Increases Na,K-ATPase Cell Surface Expression via Enhanced Na+ Influx in Cultured Renal Collecting Duct Cells
J. Am. Soc. Nephrol.,
October 1, 2004;
15(10):
2537 - 2547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Summa, S. M. R. Camargo, C. Bauch, M. Zecevic, and F. Verrey
Isoform specificity of human Na+,K+-ATPase localization and aldosterone regulation in mouse kidney cells
J. Physiol.,
March 1, 2004;
555(2):
355 - 364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lebowitz, B. An, R. S. Edinger, M. L. Zeidel, and J. P. Johnson
Effect of altered Na+ entry on expression of apical and basolateral transport proteins in A6 epithelia
Am J Physiol Renal Physiol,
September 1, 2003;
285(3):
F524 - F531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vinciguerra, G. Deschenes, U. Hasler, D. Mordasini, M. Rousselot, A. Doucet, A. Vandewalle, P.-Y. Martin, and E. Feraille
Intracellular Na+ Controls Cell Surface Expression of Na,K-ATPase via a cAMP-independent PKA Pathway in Mammalian Kidney Collecting Duct Cells
Mol. Biol. Cell,
July 1, 2003;
14(7):
2677 - 2688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-E. Rafestin-Oblin, J. Fagart, A. Souque, C. Seguin, M. Bens, and A. Vandewalle
11beta -Hydroxyprogesterone Acts as a Mineralocorticoid Agonist in Stimulating Na+ Absorption in Mammalian Principal Cortical Collecting Duct Cells
Mol. Pharmacol.,
December 1, 2002;
62(6):
1306 - 1313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Hasler, D. Mordasini, M. Bens, M. Bianchi, F. Cluzeaud, M. Rousselot, A. Vandewalle, E. Feraille, and P.-Y. Martin
Long Term Regulation of Aquaporin-2 Expression in Vasopressin-responsive Renal Collecting Duct Principal Cells
J. Biol. Chem.,
March 15, 2002;
277(12):
10379 - 10386.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|